Your email has been successfully added to our mailing list.

×
0.0418181818181818 0.0418181818181818 0.0418181818181818 0.0418181818181818 0.116256684491979 0.188235294117647 0.309304812834224 0.235294117647059
Stock impact report

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

PRANA BIOTECH (PRAN) 
US:NASDAQ Investor Relations: pranabio.com/investors
Company Research Source: Business Wire
Highlights: Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT434 to prevent a-synuclein accumulation and neuron loss in experimental animal models of parkinsonian diseases Transition to human trials is a milestone for the Company building on its well-established scientific foundations Highly experienced drug development team, based in San Francisco, leading the program MELBOURNE, Australia & SAN FRANCISCO--(BUSINESS WIRE)-- Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) is pleased to announce the first cohort of volunteers in its Phase I clinical trial have been administered PBT434, an experimental drug under investigation for the treatment of Parkinsonian diseases. The trial conducted in Melbourne, Australia is recruiting and dosing healt Show less Read more
Impact Snapshot
Event Time:
PRAN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PRAN alerts
Opt-in for
PRAN alerts

from News Quantified
Opt-in for
PRAN alerts

from News Quantified